```html

Infection‑Related Acute Kidney Injury (AKI)

Overview

Acute kidney injury (AKI) is a sudden decline in kidney function that develops over hours to days. When an infection—bacterial, viral, fungal, or parasitic—triggers or worsens this decline, the condition is called infection‑related AKI. It is a medical emergency because kidneys filter waste, balance fluids, and regulate electrolytes; rapid loss of these functions can damage other organs.

Who it affects

• Older adults (≥65 years) – age‑related decline in renal reserve makes them vulnerable.
• Patients with chronic kidney disease (CKD), diabetes, or hypertension.
• Critically ill individuals in intensive‑care units (ICU), especially those with sepsis.
• Children with severe infections (e.g., meningococcemia) can also develop AKI.

Prevalence

• In the United States, AKI occurs in up to 13–18 % of hospitalized patients. Infection‑related cases account for roughly 30–40 % of these.
• Sepsis is the leading cause of AKI in ICU settings, with an incidence of 44–70 % among septic patients (Meyer et al., *JAMA*, 2022).
• Mortality rises from 10–15 % in non‑infectious AKI to 30–50 % when infection is the precipitant.

Symptoms

Symptoms reflect both the underlying infection and the loss of kidney function. Not all patients experience every sign; some may have only subtle changes in urine output.

General infection signs

• Fever or hypothermia – body temperature >38 °C (100.4 °F) or <35 °C (95 °F).
• Chills, rigors – shaking chills are typical of bacteremia.
• Rapid heart rate (tachycardia) and low blood pressure (hypotension), especially in sepsis.
• Fatigue, malaise, confusion – systemic inflammatory response.

Kidney‑specific manifestations

• Oliguria – urine output < 0.5 mL/kg/hr for ≥6 hours.
• Anuria – virtually no urine (< 100 mL/24 h).
• Edema – swelling of legs, ankles, or periorbital area due to fluid retention.
• Elevated serum creatinine – rise of ≥0.3 mg/dL (≥26.5 µmol/L) within 48 h or a 1.5‑fold increase from baseline.
• Electrolyte abnormalities – hyperkalemia, metabolic acidosis, hyponatremia.
• Uremic symptoms – nausea, vomiting, loss of appetite, itching, or mental status changes when waste accumulates.

Causes and Risk Factors

How infection leads to AKI

1. Sepsis‑induced hemodynamic changes – widespread vasodilation and capillary leakage lower renal perfusion.
2. Inflammatory cytokines (TNF‑α, IL‑6) cause direct tubular injury.
3. Endotoxin‑mediated microvascular thrombosis blocks glomerular flow.
4. Direct microbial invasion – pyelonephritis, viral nephritis (e.g., hantavirus, COVID‑19).
5. Nephrotoxic medications used to treat infection – aminoglycosides, amphotericin B, high‑dose vancomycin.
6. Obstructive complications – urinary tract obstruction from sloughed tissue or fungal balls.

Key risk factors

• Severe bacterial infections (e.g., **gram‑negative sepsis**, **pneumonia**, **intra‑abdominal abscess**)
• Viral illnesses with renal tropism (e.g., **Hantavirus, SARS‑CoV‑2, HIV**)
• Fungal infections, especially in immunocompromised hosts.
• Pre‑existing CKD, especially stage 3 or higher.
• Diabetes mellitus, hypertension, and cardiovascular disease.
• Use of nephrotoxic antibiotics, contrast agents, or NSAIDs during illness.
• Volume depletion from vomiting, diarrhea, or diuretics.
• Age >65 years, low body weight, and malnutrition.

Diagnosis

Prompt diagnosis hinges on clinical suspicion, laboratory trends, and imaging when indicated.

Initial assessment

• History – recent infection, medication exposure, baseline kidney function.
• Physical exam – blood pressure, perfusion status, edema, signs of infection source.

Laboratory tests

1. Serum creatinine & blood urea nitrogen (BUN) – track rise over 48 h.
2. Estimated glomerular filtration rate (eGFR) – calculated with CKD‑EPI equation.
3. Electrolytes – potassium, sodium, bicarbonate, calcium, phosphorus.
4. Complete blood count – leukocytosis or leukopenia indicating infection severity.
5. Inflammatory markers – C‑reactive protein (CRP), procalcitonin (helpful to gauge bacterial sepsis).
6. Urinalysis – looks for pyuria, casts, protein, or hematuria.
7. Blood cultures – at least two sets before antibiotics if sepsis suspected.
8. Serum lactate – elevated in septic shock.

Imaging

• Renal ultrasound – rules out obstruction or renal vein thrombosis.
• CT abdomen/pelvis with contrast – used cautiously; contrast‑induced AKI risk must be weighed.

Diagnostic criteria

KDIGO (Kidney Disease: Improving Global Outcomes) defines AKI as any of the following:

• Increase in serum creatinine ≥0.3 mg/dL (≥26.5 µmol/L) within 48 h.
• Increase in serum creatinine to ≥1.5 times baseline, known or presumed to have occurred within the prior 7 days.
• Urine output < 0.5 mL/kg/h for ≥6 h.

Treatment Options

Treatment is two‑pronged: eradicate the infection and protect/restore kidney function.

1. Infection control

• Empiric broad‑spectrum antibiotics within the first hour of sepsis recognition (e.g., cefepime + vancomycin) – adjust per culture results.
• Antiviral therapy when indicated (e.g., remdesivir for severe COVID‑19, ganciclovir for CMV).
• Antifungal agents (e.g., echinocandins) for suspected invasive candidiasis.
• Source control – drainage of abscesses, removal of infected catheters, surgical debridement.

2. Hemodynamic support

• Goal‑directed fluid resuscitation with isotonic crystalloids (e.g., lactated Ringer’s). Target mean arterial pressure (MAP) ≥ 65 mmHg.
• Vasopressors (norepinephrine first‑line) if hypotension persists despite fluids.
• Inotropes (dobutamine) for cardiac dysfunction when cardiac output is low.

3. Renal‑specific interventions

• Avoid further nephrotoxins – stop or dose‑adjust aminoglycosides, NSAIDs, IV contrast.
• Diuretics (e.g., furosemide) may be used to manage volume overload but do not improve outcomes when used prophylactically.
• Renal replacement therapy (RRT) – indicated for refractory hyperkalemia, severe acidosis, volume overload, or uremic complications. Options include intermittent hemodialysis, continuous renal replacement therapy (CRRT), or peritoneal dialysis.
• Adjunctive therapies – low‑dose corticosteroids in septic shock per Surviving Sepsis Guidelines, though evidence for direct renal protection is limited.

4. Supportive care

• Maintain normoglycemia (target 140‑180 mg/dL) – hyperglycemia worsens AKI.
• Electrolyte management – calcium gluconate for severe hyperkalemia, bicarbonate for metabolic acidosis.
• Nutritional support – adequate protein (0.8‑1.0 g/kg/day) without overloading the kidneys.

Living with Infection‑Related Acute Kidney Injury

Even after hospital discharge, many patients need ongoing care to prevent progression and promote recovery.

Medication management

• Take prescribed antibiotics exactly as directed; never reuse leftover doses.
• Inform all providers of recent AKI; many drugs require dose adjustment (e.g., ACE inhibitors, diuretics, certain pain relievers).
• Use a medication list or app to track dosing changes.

Fluid & electrolyte balance

• Follow fluid recommendations from your nephrologist – often 1.5–2 L/day unless volume overloaded.
• Monitor weight daily; a sudden rise >2 kg may signal fluid retention.
• Limit high‑potassium foods (bananas, oranges, potatoes) if potassium remains elevated.

Follow‑up care

• Schedule lab checks (creatinine, eGFR, electrolytes) within 1–2 weeks post‑discharge, then at intervals your doctor advises.
• Attend all nephrology appointments; early detection of residual kidney impairment improves outcomes.

Lifestyle tips

• Adopt a kidney‑friendly diet: moderate protein, low sodium (<2 g/day), adequate calories.
• Stay physically active within tolerance – walking, gentle resistance training improves circulation.
• Avoid over‑the‑counter NSAIDs and herbal supplements that may harm kidneys.
• Vaccinations (influenza, pneumococcal, COVID‑19, hepatitis B) reduce future infection risk.

Prevention

Many cases of infection‑related AKI are preventable with early infection control and kidney‑protective habits.

• Prompt treatment of infections – seek medical care for fevers, urinary symptoms, or wound drainage.
• Hand hygiene and infection‑control practices – especially in hospitals or long‑term care facilities.
• Vaccination – CDC recommends annual flu vaccine, COVID‑19 booster, and pneumococcal vaccines for high‑risk adults.
• Hydration – maintain adequate oral fluid intake; increase fluids during diarrheal illnesses unless contraindicated.
• Medication safety – discuss nephrotoxic drug alternatives with your clinician; use the lowest effective dose.
• Monitoring chronic conditions – tightly control diabetes, blood pressure, and heart failure to preserve baseline kidney function.

Complications

If infection‑related AKI is not promptly treated, several serious complications can arise:

• Progression to chronic kidney disease (CKD) – up to 30 % of survivors develop CKD stage 3 or higher.
• Persistent electrolyte disturbances – especially hyperkalemia leading to cardiac arrhythmias.
• Volume overload – pulmonary edema, worsening heart failure.
• Uremic syndrome – pericarditis, encephalopathy, platelet dysfunction causing bleeding.
• Multiorgan failure – kidneys, lungs, liver, and brain can be simultaneously compromised in severe sepsis.
• Increased mortality – as noted, infection‑related AKI doubles the risk of in‑hospital death compared with non‑infectious AKI.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), KDIGO Clinical Practice Guideline for AKI 2021, Surviving Sepsis Campaign 2023, JAMA 2022; Meyer et al., Acute Kidney Injury in Sepsis, and WHO guidelines on infection prevention.

```